Partnerships

The Pacific Pediatric Neuro-Oncology Consortium (PNOC) is an international consortium with study sites within the United States, Canada, Europe and Australia. PNOC is dedicated to bringing new therapies to children and young adults with brain tumors - with the goal to improve outcomes by translating

Neurofibromatosis 2 (NF2) is a rare genetic disorder that is primarily characterized by noncancerous (benign) tumors of the nerves that transmit balance and sound impulses from the inner ears to the brain (bilateral acoustic neuromas/vestibular schwannomas). NF Biosolutions is partnering with CBTN o

The ETMR One Registry has partnered with The Children’s Brain Tumor Network (CBTN) for the collection and processing of high-quality ETMR biospecimens and the associated genomic analysis of these tumor samples. Together, we aim to develop ETMR cell lines and transplantable tumor models which will be

The Chordoma Foundation Biobank initiative will share biospecimens, clinical and genomic data via the expertise and tools created by the CBTN's Operations Center at CHOP to accelerate chordoma biospecimen based research. CBTN Operations will serve as not only the central biospecimen repository but a

Project OPEN Oligo will define a new accelerated model for increasing ‘real-time’ collaborative research to empower discovery of improved treatments for people diagnosed with an Oligodendroglioma across a data-driven clinical trial and basic research ecosystem.

CBTN has partnered with the Treehouse initiative and provided pediatric brain tumor data to be part of their analysis platforms and initatives.

CTBN has partnered with GA4GH with the goal of international global data sharing.

CBTN has partnered with CCDL to perform a landscape analysis on the CBTN's Pediatric Brain Tumor Atlas.

CBTN has partnered with ICGC in their global initiative for large scale genomics data analysis by providing the CBTN for their translational initiatives.

The Gabriella Miller Kids First Data Resource Center (Kids First DRC) is an NIH-Common Fund supported collaborative, pediatric research effort with the goal of understanding the genetic causes and links between childhood cancer and structural birth defects.

Launched in September of 2018, the Human Tumor Atlas Network (HTAN) is a National Cancer Institute (NCI)-funded Cancer MoonshotSM initiative through which a collaborative network of Research Centers and a central Data Coordinating Center are constructing 3-dimensional atlases of the cellular, morpho

The National Cancer Institute's Childhood Cancer Data Initiative (CCDI) focuses on the critical need to collect, analyze, and share data to address the burden of cancer in children, adolescents, and young adults (AYAs). The initiative supports maximizing the use and benefit of data from childhood an

Individualized Paediatric Cure's project team focuses on identifying effective personalized medicine for paediatric cancers to address the multitude of challenges within the childhood cancer community. This comprehensive computational effort combines an extensive knowledge base, machine-learning, an

ZERO is Australia’s first-ever personalized medicine program for children and young people with high-risk cancer. Using cutting-edge science, the latest technology, and the brightest minds in research and clinical care, it is changing the model of care for children with cancer.Led by Children’s Canc

The NIH Cloud Platform Interoperability Effort (NCPI) will establish and implement guidelines and technical standards to empower end-user analyses across participating platforms and facilitate the realization of a trans-NIH, federated data ecosystem.The NCPI was created as an outcome of the NIH Work